To: Australian Securities and Investments Commission (ASIC)Subject: Whistleblower Report Regarding Suspected Insider Trading Involving [Company Name]Dear ASIC Officers,I am writing to formally report a serious case of suspected insider trading involving [Full Company Name] (Ticker: , hereafter referred to as “[Abbreviation]”) in connection with the company’s recent clinical trial results.According to publicly available information, [Company Name] announced on [Date, e.g., 10 April 2025] that its pivotal clinical trial failed to meet its primary endpoints. However, the day before this announcement ([Date]), the company’s share price experienced a sharp and unusual decline, accompanied by a significant surge in trading volume—well beyond normal market fluctuations.This timing and the nature of the trading activity strongly suggest that certain market participants may have gained access to material, non-public information regarding the clinical trial results, and acted on this information to sell off shares ahead of the public announcement, thereby avoiding losses.If this is the case, it would represent a clear breach of insider trading laws and an egregious violation of market integrity, to the detriment of ordinary investors and public trust.I respectfully urge ASIC to investigate the following:Review trading records between [Start Date] and [Announcement Date] for unusual or suspicious activity;Examine trading behavior of individuals with access to the clinical trial results, including company executives, employees, collaborators, and their immediate associates;Determine whether there was any unlawful disclosure or leakage of confidential information prior to the public announcement;If insider trading is confirmed, take appropriate enforcement action and publish the findings to uphold market transparency.I appreciate ASIC’s continued efforts to ensure fairness and transparency in Australia’s financial markets, and I sincerely hope that this case will be thoroughly examined.I am willing to cooperate further and provide additional information within the scope permitted by law.Yours faithfully,[Your Name (or “Anonymous” if preferred)]Contact Information: [Email/Phone – optional]Date: [Insert Date]
Expand
(20min delay)